Ventrix
Ventrix Bio is a leader in ECM bioTherapeutics, focused on creating a new class of biotherapeutics that leverage the benefits of native extracellular matrix (ECM) to guide the body's natural repair processes and generate healthy tissue microenvironments. ECM is essential for tissue repair and cellular functions, and Ventrix aims to harness this for innovative medical solutions.
Industries
Nr. of Employees
small (1-50)
Ventrix
San Diego, California, United States, North America
Patents
Products
ECM-derived scaffold/hydrogel for tissue repair
An extracellular matrix–based material formulated as a scaffold or gel intended to recreate native microenvironmental cues and support tissue regeneration.
ECM-derived scaffold/hydrogel for tissue repair
An extracellular matrix–based material formulated as a scaffold or gel intended to recreate native microenvironmental cues and support tissue regeneration.
Services
Research and product development of therapeutics derived from native extracellular matrix intended to restore or recreate tissue-specific microenvironments and support repair.
Research and product development of therapeutics derived from native extracellular matrix intended to restore or recreate tissue-specific microenvironments and support repair.
Expertise Areas
- Extracellular matrix-based therapeutics
- Regenerative medicine and tissue repair
- Biomaterials formulation and scaffold design
- Hydrogel and scaffold delivery formats
Key Technologies
- Extracellular matrix biomaterials
- Hydrogel scaffolds
- Decellularization and ECM processing
- Biomaterial formulation